A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC)
Clinical trial NCT02034552 · COMPLETED
Trial details
- NCT number
- NCT02034552
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-07
- Primary completion
- 2016-07-15
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.